Hydrogen sulfide donor sodium hydrosulfide modulates ovarian steroidogenesis and follicular integrity in a DHEA-induced rat model of polycystic ovary syndrome - Summary - MDSpire

Hydrogen sulfide donor sodium hydrosulfide modulates ovarian steroidogenesis and follicular integrity in a DHEA-induced rat model of polycystic ovary syndrome

  • By

  • Aysun Ozbay Onal

  • Nadiye Koroglu

  • Alev Cumbul

  • Engin Sumer

  • Kubra Acikalin Coskun

  • June 19, 2026

  • 0 min

Share

Objective:

To investigate the effects of the H2S donor sodium hydrosulfide (NaHS) on ovarian steroidogenesis, apoptosis, and follicular remodeling in a dehydroepiandrosterone (DHEA)-induced rat model of polycystic ovary syndrome (PCOS).

Approach:
    Key Findings:
    • DHEA treatment disrupted estrous cyclicity and elevated serum estradiol and progesterone levels.
    • DHEA reduced numbers of primordial, primary, Graafian follicles, and corpora lutea, while increasing cystic and atretic follicles.
    • NaHS administration improved estrous cyclicity, reduced follicular damage and apoptosis, and downregulated steroidogenic enzyme overexpression, while partially restoring CBS and CTH expression.
    Interpretation:

    NaHS modulated steroidogenic enzyme expression, apoptotic activity, and follicular architecture in a DHEA-induced PCOS model.

    Limitations:
    • Sample size determination was not based on formal power analysis due to insufficient variance data.
    • The study was conducted in a rat model, which may not fully replicate human PCOS.
    Conclusion:

    Pharmacological supplementation with NaHS may influence ovarian health and steroidogenesis in PCOS, warranting further mechanistic investigation.

Original Source(s)

Related Content